Reactions 1680, p143 - 2 Dec 2017 Neutropenia and stomatitis: case report An 82-year-old woman developed neutropenia and stomatitis during treatment with fluorouracil, folinic acid and oxaliplatin [mFOLFOX6; routes, dosages, durations of treatments to reaction onsets and outcomes not stated]. The woman, who had history of cStage IIIb rectal cancer diagnosed in April 2015, started receiving mFOLFOX6 chemotherapy with fluorouracil, folinic acid and oxaliplatin following stoma creation. She received standard doses of the mFOLFOX6 chemotherapy. However, after the first course, she developed both grade III stomatitis and neutropenia toxicities. Hence, the woman’s chemotherapy dose was reduced by 20% and continued. Later, she underwent low anterior resection with lymphadenectomy and got discharged. Twenty months following the surgery, no relapse of the rectal cancer was observed. Author comment: "[T]hen standard dose of mFOLFOX6 was initiated. Although grade 3 toxicities of neutropenia and stomatitis were observed after first course, chemotherapy continued with 20% dose reduction." Usuda A, et al. An elderly patient with marginally unresectable rectal cancer obtained pathological complete response by the treatment with mFOLFOX6. Annals of Cancer Research and Therapy 25: 83-87, No. 2, 2017. Available from: URL: http://doi.org/10.4993/acrt.25.83 - Japan 803284027 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera